Cargando…

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk

OBJECTIVE: To examine real-world treatment patterns of lipid-lowering treatment and their possible associated intolerance and/or ineffectiveness among patients with type 2 diabetes mellitus initiating statins and/or ezetimibe. RESEARCH DESIGN AND METHODS: Adult (aged ≥18 years) patients diagnosed wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quek, Ruben G W, Fox, Kathleen M, Wang, Li, Li, Lu, Gandra, Shravanthi R, Wong, Nathan D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586941/ https://www.ncbi.nlm.nih.gov/pubmed/26435839 http://dx.doi.org/10.1136/bmjdrc-2015-000132

Ejemplares similares

Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden
por: Karlsson, Sofia Axia, et al.
Publicado: (2019)

Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
por: Shah, Baiju R., et al.
Publicado: (2008)

Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam Study
por: Ahmadizar, Fariba, et al.
Publicado: (2021)

ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk
por: Zhang, Hongmei, et al.
Publicado: (2020)

Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics
por: Youk, Tae Mi, et al.
Publicado: (2020)

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
por: Scott, Russell, et al.
Publicado: (2009)

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
por: Matsumoto, Chisa, et al.
Publicado: (2022)

Impact of type 2 diabetes and microvascular complications on mortality and cardiovascular outcomes in a multiethnic Asian population
por: Yap, Jonathan, et al.
Publicado: (2021)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study
por: Zhao, Maoxiang, et al.
Publicado: (2021)

Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2020)

Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia
por: Bello, Natalie A, et al.
Publicado: (2014)

Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus
por: Mencke, Rik, et al.
Publicado: (2021)

Levels of ankle–brachial index and the risk of diabetes mellitus complications
por: Alves-Cabratosa, Lia, et al.
Publicado: (2020)

Maternal Cardiac Changes in Women With Obesity and Gestational Diabetes Mellitus
por: Thirunavukarasu, Sharmaine, et al.
Publicado: (2022)

Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
por: Soliman, Elsayed Z., et al.
Publicado: (2017)

Hispanic representation in diabetes cardiovascular outcomes trials
por: Kelley, A. Taylor, et al.
Publicado: (2019)

Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2022)

Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
por: Birukov, Anna, et al.
Publicado: (2022)

Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register
por: Cederholm, Jan, et al.
Publicado: (2008)

Association between brachial-ankle pulse wave velocity and risk of type 2 diabetes mellitus: results from a cohort study
por: Lou, Yan-mei, et al.
Publicado: (2020)

Increased Daily Walking Improves Lipid Oxidation Without Changes in Mitochondrial Function in Type 2 Diabetes
por: Trenell, Michael I., et al.
Publicado: (2008)

Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms
por: West, Nancy A., et al.
Publicado: (2009)

Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease
por: Rother, Ulrich, et al.
Publicado: (2020)

Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial
por: Menon, Venu, et al.
Publicado: (2020)

Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
por: Chowdhury, Mahin, et al.
Publicado: (2021)

Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial
por: Margolis, Karen L., et al.
Publicado: (2014)

Ideal Cardiovascular Health and the Prevalence and Progression of Coronary Artery Calcification in Adults With and Without Type 1 Diabetes
por: Alman, Amy C., et al.
Publicado: (2014)

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
por: Koska, Juraj, et al.
Publicado: (2018)

Type 2 diabetes and the risk of cardiovascular events in peripheral artery disease versus coronary artery disease
por: Sprenger, Lukas, et al.
Publicado: (2021)

Heart Rate–Corrected QT Interval Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Diabetes Heart Study
por: Cox, Amanda J., et al.
Publicado: (2014)

Prevalence and major risk factors of type 2 diabetes mellitus among adult psychiatric inpatients from 2005 to 2018 in Beijing, China: a longitudinal observational study
por: Yang, Fude, et al.
Publicado: (2020)

Cardiovascular and Renal Disease Burden in Type 1 Compared With Type 2 Diabetes: A Two-Country Nationwide Observational Study
por: Kristófi, Robin, et al.
Publicado: (2021)

Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis
por: McMillan, Jacqueline M, et al.
Publicado: (2018)

Insulin treatment in patients with diabetes mellitus and heart failure in the era of new antidiabetic medications
por: Staszewsky, Lidia, et al.
Publicado: (2022)

Effect of resistance training on HbA1c in adults with type 2 diabetes mellitus and the moderating effect of changes in muscular strength: a systematic review and meta-analysis
por: Jansson, Anna K, et al.
Publicado: (2022)

Association of Maternal Folate and Vitamin B(12) in Early Pregnancy With Gestational Diabetes Mellitus: A Prospective Cohort Study
por: Chen, Xiaotian, et al.
Publicado: (2021)

Pre-diabetes, diabetes and fluctuations of glucose tolerance after gestational diabetes mellitus: 5-year follow-up of a contemporary, prospective study in Germany
por: Haschka, Stefanie J, et al.
Publicado: (2022)

Role of resistin, IL-6 and NH2-terminal portion proBNP in the pathogenesis of cardiac disease in type 2 diabetes mellitus
por: Ghanem, Samar Ebrahim, et al.
Publicado: (2020)

Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study
por: An, Yali, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_llgsqoflbh8eh5ctcoclioilho